NIH-funded research R01 grant

Understanding how HIV-1 matures to become infectious

Official title: Determining the molecular mechanisms of HIV-1 maturation

Funded at University of Delaware · NIH-11406177 · Data updated 2026-11-12

Scientists are studying how HIV-1 particles transform during maturation to become capable of infecting cells, using advanced computer simulations to uncover the steps involved.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Delaware
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startAugust 15, 2023
Project endJuly 31, 2028
Funding year2026
Award (this year)$563,977
NIH project number5R01AI178846-04
Project IDNIH-11406177 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to individual patients in this grant; focuses on molecular mechanisms using computational models and prior knowledge of human HIV-1 biology.

Less likely to help

There is no direct patient participation in this computational/biophysical study.

What this research studies

This project uses a combination of advanced computer simulations to model HIV-1 maturation, linking how the Gag polyprotein is cut and rearranges with changes in the viral membrane and capsid. By integrating coarse-grained and atomistic methods, researchers aim to reveal the motion and structural changes that drive maturation. The findings could point to new ways to block maturation and prevent infection. The work is based at the University of Delaware with collaboration across disciplines.

Why it matters

Potential benefit: If successful, the research could identify new targets to disrupt HIV-1 maturation and reduce infectivity, guiding future therapies.

How similar studies have gone: Prior structural studies have advanced understanding of HIV-1 maturation; this project advances by integrating dynamic simulations, which is a promising but complex next step.

Where this research is happening

  • University of Delaware
    Newark, United States
    Active

Researchers

  • Principal investigator: Perilla Jimenez, Juan Roberto — University of Delaware
  • Study coordinator: Perilla Jimenez, Juan Roberto

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.